FREQUENTLY ASKED QUESTIONS.
BANAMINE® TRANSDERMAL FAQS
These FAQs should answer most of your questions, but if there is something more you want to know, you can always contact us for more information.
IS THERE CONCERN OVER ANIMALS LICKING BANAMINE TRANSDERMAL FROM TREATED ANIMALS?
Cattle must not be slaughtered for human consumption within eight days of treatment. Milk must not be used for human consumption for 48 hours after treatment.
SHOULD THE DOSE BE ADJUSTED BASED ON AIR TEMPERATURES?
There is no need to adjust the dose. While studies demonstrated peak plasma flunixin concentrations were consistently lower when the pour-on product was administered in cold temperatures vs. hot temperatures, the bioavailability is the same. Clinical effectiveness was demonstrated over a range of environmental temperatures expected under field conditions.
IS THERE CONCERN OVER ANIMALS LICKING BANAMINE TRANSDERMAL FROM TREATED ANIMALS?
No. A study where animals were allowed to self-lick or lick pen mates demonstrated a lower rate and extent of absorption when compared to the animals prevented from licking. However, no dose adjustment is needed to account for the effect of licking because substantial evidence of effectiveness was demonstrated in animals that were allowed to lick1.
1. Key Points Regarding the Pharmacokinetics of BANAMINE® TRANSDERMAL
Important Safety Information
Banamine TD: NOT FOR HUMAN USE. KEEP OUT OF REACH OF CHILDREN. Milk that has been taken during treatment and for 48 hours after treatment must not be used for human consumption. Cattle must not be slaughtered for human consumption within 8 days of the last treatment. Not for use in replacement dairy heifers 20 months of age or older or dry dairy cows; use in these cattle may cause drug residues in milk and/or calves born to these cows or heifers. Not for use in beef and dairy bulls intended for breeding over 1 year of age, beef calves less than 2 months of age, dairy calves, and veal calves. Do not use within 48 hours of expected parturition. Approved only as a single topical dose in cattle. For complete information on BANAMINE® TRANSDERMAL, see accompanying product package insert.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global